Trend in Prevalence of Uncontrolled Total Serum Cholesterol for Cardio-cerebro-vascular Disease in a Mediterranean Area, 1988/89-2008/09

Overview

Journal World J Cardiol

Publisher Baishideng Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2013 Dec 17

PMID 24340140

Citations 1

Authors

Vincenzo Capuano

Norman Lamaida

Ernesto Capuano

Maria Immacolata Borrelli

Rocco Capuano

Elisabetta Notari

Anna Grazia Iannone

Federica Marchese

Matteo Sonderegger

Eduardo Capuano

Affiliations

Soon will be listed here.

Abstract

Aim: To examine trends of uncontrolled total serum cholesterol, treatment and control in a Mediterranean region (Campania).

Methods: We considered and compared the data collected as part of "Montecorvino Rovella Project" 1988-1989 and cross-sectional data from the two phases of the "VIP Project-Valle dell'Irno Prevenzione": 1998-1999 (1(st) phase) and 2008-2009 (2(nd) phase), in the 35-74-year-old-population.

Results: Data show a reduction of mean cholesterolemia in the last twenty years of 7.3 mg/dL for men and unchanged values for women. In the three surveys the mean values for serum cholesterol are in men: 205.2 ± 47.1 mg/dL (1988/89), 200 ± 38.9 mg/dL (1998/99) and 197.9 ± 40.2 mg/dL (2008/09); in the women: 203.1 ± 42.5 mg/dL (1988/89), 198.9 ± 37.9 mg/dL (1998/99) and 203.3 ± 39.3 mg/dL (2008/09). Prevalence of uncontrolled high cholesterol ≥ 240 mg/dL for men decreased from 20.8% (1988/89) to 14.3% (1998/99) and 13.9% (2008/9), P = 0.002; for women the values decreased from 19.9% (1988/89), to 18.2% (1998/99) and 18.1% (2008/09), P = 0.007. Is statistically increased the number of patients treated and those treated to target.

Conclusion: Encouraging increases in awareness, treatment, and control of hypercholesterolemia occurred from 1988 through 2008. Nevertheless, control of hypercholesterolemia remains poor.

Citing Articles

Implications of medical screenings of patients arriving for dental treatment: the results of a comprehensive laboratory screening.

Miller C, Westgate P J Am Dent Assoc. 2014; 145(10):1027-35.

PMID: 25270701 PMC: 4388436. DOI: 10.14219/jada.2014.69.

References

Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J . Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370(9602):1829-39. DOI: 10.1016/S0140-6736(07)61778-4. View

Capuano V, Bambacaro A, DArminio T, Del Regno B, DAntonio V, Lanzara C . Changes in total serum cholesterol for cardiovascular disease in a Mediterranean area, 1989-1999. Eur J Epidemiol. 2003; 18(1):27-32. DOI: 10.1023/a:1022533117139. View

Sjol A, Grunnet K, Schroll M . Secular trends in serum cholesterol, high density lipoproteins and triglycerides 1964-1987. Int J Epidemiol. 1991; 20(1):105-13. DOI: 10.1093/ije/20.1.105. View

Capuano V, DArminio T, Bambacaro A, Lanzara C, DAntonio V . [The VIP Project: prevalence of risk factors for ischemic cardiopathy in an area of Campania]. Ital Heart J Suppl. 2002; 2(11):1201-8. View

Brugts J, Yetgin T, Hoeks S, Gotto A, Shepherd J, Westendorp R . The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 2009; 338:b2376. PMC: 2714690. DOI: 10.1136/bmj.b2376. View

Krumholz H, Douglas P, Lauer M, Pasternak R . Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias?. Ann Intern Med. 1992; 116(10):785-90. DOI: 10.7326/0003-4819-116-10-785. View

Capuano V, DArminio T, La Sala G, Mazzotta G . The third component of the complement (C3) is a marker of the risk of atherogenesis. Eur J Cardiovasc Prev Rehabil. 2006; 13(4):658-60. DOI: 10.1097/01.hjr.0000224485.80349.76. View

Ezzati M, Lopez A, Rodgers A, Vander Hoorn S, Murray C . Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360(9343):1347-60. DOI: 10.1016/S0140-6736(02)11403-6. View

Capuano V, Lamaida N, De Martino M, Punzi M, De Vita S, Riccio M . [The Montecorvino Rovella Project: prevalence of coronary disease risk factors in an area of Campania]. G Ital Cardiol. 1994; 24(4):399-408. View

10.

Mancini M, Rubba P . The Mediterranean diet in Italy. World Rev Nutr Diet. 2000; 87:114-26. DOI: 10.1159/000059724. View

11.

Baigent C, Blackwell L, Emberson J, Holland L, Reith C, Bhala N . Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010; 376(9753):1670-81. PMC: 2988224. DOI: 10.1016/S0140-6736(10)61350-5. View

12.

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

13.

Evans A, Tolonen H, Hense H, Ferrario M, Sans S, Kuulasmaa K . Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol. 2002; 30 Suppl 1:S35-40. DOI: 10.1093/ije/30.suppl_1.s35. View

14.

Carroll M, Lacher D, Sorlie P, Cleeman J, Gordon D, Wolz M . Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005; 294(14):1773-81. DOI: 10.1001/jama.294.14.1773. View

15.

Guilbert J . The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon). 2004; 16(2):230. DOI: 10.1080/1357628031000116808. View

16.

Kuklina E, Yoon P, Keenan N . Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA. 2009; 302(19):2104-10. DOI: 10.1001/jama.2009.1672. View

17.

Tofler G, Stone P, Muller J, Willich S, Davis V, Poole W . Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987; 9(3):473-82. DOI: 10.1016/s0735-1097(87)80038-4. View

18.

Keys A . From Naples to seven countries--a sentimental journey. Prog Biochem Pharmacol. 1983; 19:1-30. View

19.

Eliasson M, Janlert U, Jansson J, Stegmayr B . Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006; 260(6):551-9. DOI: 10.1111/j.1365-2796.2006.01730.x. View

20.

Nichols M, Townsend N, Scarborough P, Rayner M . Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013; 34(39):3017-27. PMC: 3796269. DOI: 10.1093/eurheartj/eht159. View